Lenalidomide with Low- or High-Dose Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma (MM)
Efficacy and Safety of FOLFIRINOX in Patients with Metastatic Pancreatic Cancer
Slides from presentations at ASH 2010 and transcribed comments from a recent interview with Rafael Fonseca, MD (12/22/10)
Conroy T et al. Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial. Proc ASCO 2010;Abstract 4010. |
||||||||